Monkeypox
Online inquiry

We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.

* Name
* Phone
* Email
* Products or Services Interested
Project Description

Integrated Preclinical Research Solution for Red Deer Parapoxvirus in Drug Discovery & Diagnostics

Overview

The belongs to the Parapoxvirus genus and causes skin lesions mainly in red deer. Skin lesions provoked by Parapoxvirus of Red Deer show up on animals' heads, necks, and limbs which resulting in pain along with risks of secondary infections and health issues. Most parapoxvirus strains target livestock animals such as sheep and goats, but the Red Deer variant stands out due to its impact on wildlife populations. Infected animals or contaminated environments facilitate the spread of the virus through direct contact with people. Infections tend to clear up independently, but develop into serious conditions involving young animals or those with weakened immune defenses. Red Deer Parapoxvirus demonstrates comparable characteristics with other Parapoxviruses responsible for Orf in sheep and Pseudocowpox in cattle. The study of this virus enables scientists to collect vital data that aids in creating vaccines and antiviral medications, along with wildlife health management practices. Investigating the zoonotic potential of this virus enables humans to shield themselves from possible transmission events that emerge under different circumstances. Creative Biolabs supports the development of antiviral treatments and vaccines, along with diagnostic tools for Parapoxvirus. We provide specialized services to help pharmaceutical companies and wildlife disease research organizations move therapies from laboratory research into clinical trials through valuable data and insights.

Fig.1 A picture of ORFV and PVNZ CBPs homology models. (OA Literature)Fig.1 Structure of ORFV and PVNZ CBPs homology models.1

Accelerated Parapoxvirus of Red Deer Preclinical Research Services

  • For Therapeutics Development

In Vitro Antiviral Efficacy Assays

  • Cytotoxicity Assays: To determine the maximum concentration of the therapeutic agent that does not cause cell death, ensuring the compound is safe for use in living organisms.
  • Mechanism of Action Studies: These tests determine how the therapy works (e.g., direct inhibition of viral entry, replication, or release from infected cells).
  • Neutralization Assays: If the therapeutic is antibody-based, it will be tested for its ability to neutralize the virus by preventing its binding to the host cell.
  • Time-of-Addition Studies: To determine at what point in the viral lifecycle the therapeutic acts (e.g., attachment, entry, replication, or release).

In Vivo Efficacy Studies (Animal Models)

  • Dosing and Administration: The effectiveness of various routes of administration (oral, intravenous, subcutaneous, etc.) and different dosing regimens (single dose vs. multiple doses) is evaluated.
  • Viral Load Monitoring: Viral load in tissues or fluids (e.g., blood, respiratory secretions) is measured to assess the therapeutic impact on virus replication and clearance over time.
  • Clinical Signs and Survival Analysis: The animal’s health is monitored for any signs of toxicity, disease progression, or recovery.
  • Histopathological Evaluation: Tissue samples (e.g., from lung, liver, spleen, and other relevant organs) are analyzed for signs of viral damage or therapy-induced changes, including inflammation or tissue repair.
  • For Diagnostics Development

Antigen Detection Assays

  • Enzyme-Linked Immunosorbent Assay (ELISA): Used to detect specific viral proteins or antigens in serum, tissue samples, or swabs from infected animals.
  • Immunohistochemistry (IHC): Used for detecting viral antigens in tissue samples.
  • Lateral Flow Assays (LFAs): Point-of-care devices that can rapidly detect viral antigens in field settings, useful for quick diagnostics with minimal equipment.

Nucleic Acid Detection Assays

  • Loop-Mediated Isothermal Amplification (LAMP): A rapid, cost-effective nucleic acid amplification technique that can detect PPRD DNA with high sensitivity.
  • In Situ Hybridization (ISH): Detects viral RNA in tissue samples. This can provide spatial localization of the virus within infected tissues, aiding in understanding viral replication dynamics.
  • Next-Generation Sequencing (NGS): For comprehensive genomic analysis, NGS can identify and sequence the viral genome.

Antibody Detection Assays (Serology)

  • Immunofluorescence Assay (IFA): This can be used for detecting antibodies in serum by incubating with viral antigens fixed on slides and using fluorescent-labeled secondary antibodies to visualize the immune response.
  • Lateral Flow Immunoassays (LFIA): Point-of-care devices that are widely used for detecting antibodies in serum, plasma, or whole blood samples, offering rapid results.
  • Cytometric Bead Array (CBA): A multiplex assay that can quantify multiple antibodies or cytokines in a single sample, providing insights into the immune response.

Request a quote

Products for Parapoxvirus of Red Deer Research

The generation of recombinant proteins from parapoxvirus in red deer involves inserting viral genes into expression vectors, which then express the proteins in bacterial or mammalian host cells. Researchers produce monoclonal antibodies against red deer parapoxvirus by first immunizing animals, then creating hybridomas that select antibodies that target specific viral antigens.

  • Recombinant parapoxvirus of red deer research proteins or antigens
CAT Product Name
(MPYF-1022-KX634) Magic™ Parapoxvirus of Red Deer (HL953) SB87_gp083 Recombinant Protein
(MPYF-1022-KX683) Magic™ Parapoxvirus of Red Deer (HL953) SB87_gp018 Recombinant Protein
(MPYF-1022-KX704) Magic™ Parapoxvirus of Red Deer (HL953) SB87_gp106 Recombinant Protein
(MPYF-1022-KX602) Magic™ Parapoxvirus of Red Deer (HL953) SB87_gp001 Recombinant Protein
  • Antibodies against the parapoxvirus of red deer research proteins
CAT Product Name
(MPYF-1122-KX1499) Anti-Parapoxvirus of Red Deer SB87_gp082 Monoclonal Antibody (MP-K2299) (Mouse IgG)
(MPYF-1122-KX1517) Anti-Parapoxvirus of Red Deer SB87_gp062 Monoclonal Antibody (MP-K2317) (Mouse IgG)
(MPYF-1122-KX1510) Anti-Parapoxvirus of Red Deer SB87_gp069 Monoclonal Antibody (MP-K2310) (Mouse IgG)
(MPYF-1122-KX1489) Anti-Parapoxvirus of Red Deer SB87_gp094 Monoclonal Antibody (MP-K2289) (Mouse IgG)
(MPYF-1122-KX1576) Anti-Parapoxvirus of Red Deer SB87_gp049 Monoclonal Antibody (MP-K2376) (Mouse IgG)
(MPYF-1122-KX1559) Anti-Parapoxvirus of Red Deer SB87_gp120 Monoclonal Antibody (MP-K2359) (Mouse IgG)

Get a Quote Today

Applications

1. Vaccine Development: Vaccines made from recombinant parapoxvirus proteins help safeguard red deer and other cervids against infection, which stops wildlife population outbreaks.

2. Diagnostic Tools: Diagnostic tests such as ELISA utilize parapoxvirus-specific recombinant proteins and monoclonal antibodies to detect infections in red deer while monitoring the virus's spread through wild animal populations.

3. Epidemiological Studies: The analysis of parapoxvirus distribution and frequency in red deer populations aids conservation and wildlife health management, particularly near zones where wildlife interacts with livestock.

4. Therapeutic Research: Scientists predict that recombinant proteins or monoclonal antibodies will serve as antiviral treatments for parapoxvirus infections in red deer when outbreaks threaten local wildlife populations.

Advantages

Expertise and Specialization

These companies possess specialized virology expertise, which enables thorough research on multiple viruses, including emerging types such as parapoxvirus. This ensures accurate, high-quality research and results.

Advanced Technology and Equipment

High-throughput screening, alongside genomic sequencing and viral culture systems, are essential technologies for conducting virus research. These companies benefit from modern equipment, which enables efficient and precise analysis.

Faster Time-to-Market for Therapeutics and Vaccines

Outsourcing virus research enables companies to rapidly develop antiviral drugs and vaccines, as well as diagnostic tools, which helps to decrease the time needed to launch these solutions against viral outbreaks.

Regulatory Compliance and Safety

Professional virus research organizations possess expertise in regulatory standards and safety protocols, which guarantees that their research stays within legal and ethical boundaries while working with pathogens and performing clinical trials.

FAQs

How much do virus research services cost?

Research costs change based on both the research type and its size. Virus detection and diagnostic testing usually cost less than custom research projects and vaccine or drug development initiatives. Numerous businesses design their pricing models according to individual client requirements.

Do these services assist in the creation of vaccines for newly identified viruses?

Numerous businesses focus their operations on developing vaccines through research initiatives. These companies work to detect viral antigens and evaluate vaccine candidates within preclinical and clinical trials for safety and effectiveness determination.

Many companies include data analysis and reporting as part of their service offerings?

Virus research service providers most often extend their offerings to include comprehensive data analysis and detailed report generation. The service provides interpretation of results alongside recommended next steps while presenting the data in a clear and actionable format for clients.

Reference

  1. Sharif, Saeed et al. "Chemokine-Binding Proteins Encoded by Parapoxvirus of Red Deer of New Zealand Display Evidence of Gene Duplication and Divergence of Ligand Specificity." Frontiers in microbiology vol. 10 1421. 25 Jun. 2019, DOI:10.3389/fmicb.2019.01421. Distributed under Open Access license CC BY 4.0, without modification.

We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.

Inquiry
Now